Literature DB >> 3129184

Properties of L1210 cells resistant to alpha-difluoromethylornithine.

A E Pegg1, J A Secrist, R Madhubala.   

Abstract

L1210 cells were selected for resistance to the ornithine decarboxylase (ODC) inhibitor, alpha-difluoromethylornithine. When grown in the absence of the inhibitor, these cells possessed very high ornithine decarboxylase levels. These represented about 1 part in 300 of the soluble protein, which is several hundred times greater than the maximal value found in the original L1210 cells. The resistant cells contained at least 100-fold higher levels of ODC mRNA but the half-life of ODC (about 45 min) was not altered significantly. The resistant cells had much higher putrescine and cadaverine levels than control cells, but there was no significant difference in cellular spermidine or spermine content or in production of 5'-methylthioadenosine, which is a measure of polyamine synthesis. Addition of putrescine to the control or resistant cells had no effect on their content of spermidine and spermine but addition of decarboxylated S-adenosylmethionine increased the content of spermidine and spermine. These results indicate that ornithine decarboxylase is not the rate-limiting step in polyamine synthesis in these L1210 cells. The growth of the alpha-difluoromethylornithine-resistant L1210 cells was inhibited when their ability to synthesize spermidine and spermine was blocked by the addition of the S-adenosylmethionine decarboxylase inhibitor, 5'-deoxy-5'-[N-methyl-N-(3-hydrazinopropyl)]aminoadenosine. Treatment with this compound produced a reduction of more than 85% in the production of 5'-methylthioadenosine and led to a large increase in the content of putrescine and a substantial decline in the content of spermidine and spermine. These results indicate the potential value of S-adenosylmethionine decarboxylase inhibitors as therapeutic agents in conditions where ODC inhibitors are ineffective.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129184

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.

Authors:  L M Shantz; D J Feith; A E Pegg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 2.  DNA methylation as a target for drug design.

Authors:  C M Bender; J M Zingg; P A Jones
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

3.  Effect of 1-amino-oxy-3-aminopropane on polyamine metabolism and growth of L1210 cells.

Authors:  R Poulin; J A Secrist; A E Pegg
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Investigations of the mechanism by which mammalian cell growth is inhibited by N1N12-bis(ethyl)spermine.

Authors:  L Albanese; R J Bergeron; A E Pegg
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

5.  Stable intracellular acidification upon polyamine depletion induced by alpha-difluoromethylornithine or N1,N12-bis(ethyl)spermine in L1210 leukaemia cells.

Authors:  R Poulin; A E Pegg
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

6.  Multiple regulation of ornithine decarboxylase in enzyme-overproducing cells.

Authors:  T Kameji; S Hayashi; K Hoshino; Y Kakinuma; K Igarashi
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

7.  Polyamine profiles and growth properties of ornithine decarboxylase overexpressing MCF-7 breast cancer cells in culture.

Authors:  A Manni; R Wechter; R Grove; L Wei; J Martel; L Demers
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

8.  Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system.

Authors:  Denis Soulet; Serge Rivest
Journal:  J Cell Biol       Date:  2003-07-14       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.